Alkermes (ALKS) Divestments (2015)

Alkermes (ALKS) reported Divestments of -$301000.0 for Q4 2015, down 1257.69% quarter-over-quarter from $26000.0 in Q3 2015.

Alkermes (ALKS) Divestments (2015) Analysis & Trends

Alkermes (ALKS) has 1 years of Divestments data on file, last reported at -$301000.0 in Q4 2015.

  • Divestments for Q4 2015 came in at -$301000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$301000.0 (changed N/A YoY), and the FY2025 annual result was $1.7 million, down 98.26% from the prior year.
  • Divestments declined to -$301000.0 in Q4 2015 per ALKS's latest filing, from $26000.0 in the prior quarter.
  • Over five years, Divestments peaked at $26000.0 in Q3 2015 and troughed at -$301000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 42.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 24.21 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -301,000.00
Sep 30, 2015 26,000.00